-
241
Successful Tocilizumab Therapy for Macrophage Activation Syndrome Associated with Adult-Onset Still’s Disease: A Case-Based Review
Published 2016-01-01“…TCZ initiation after adequate nonselective immunosuppressive therapy, such as methylprednisolone pulse therapy or a prednisolone-based combination of immunosuppressants, can be an effective treatment for AOSD-associated MAS. …”
Get full text
Article -
242
Incidental Finding of Nocardia: A Case Series from a Tertiary Care Centre in Uttarakhand
Published 2020-01-01“…The most common conditions causing immunosuppression were type II DM, COPD, and pulmonary tuberculosis.…”
Get full text
Article -
243
Myasthenia gravis and Lambert-Eaton myasthenic syndrome: treatment options and guidance for management during COVID-19 pandemic
Published 2020-06-01“…During the COVID-19 pandemic, MG/LEMS patients should continue ongoing treatment and are advised not to stop any immunosuppressive agents used. Altering or stopping an immunosuppressive agent may increase disease activity and/or MG exacerbation or crisis. …”
Get full text
Article -
244
Transplant Tolerance: New Insights and Strategies for Long-Term Allograft Acceptance
Published 2013-01-01“…Despite the potential of organ transplantation, the administration of immunosuppressive drugs required for allograft acceptance induces severe immunosuppression in transplanted patients, which leads to serious side effects such as infection with opportunistic pathogens and the occurrence of neoplasias, in addition to the known intrinsic toxicity of these drugs. …”
Get full text
Article -
245
Macrophages facilitate tumor cell PD‐L1 expression via an IL‐1β‐centered loop to attenuate immune checkpoint blockade
Published 2023-04-01“…Together, this study presents an IL‐1β‐centered immunosuppressive loop between TAMs and tumor cells, highlighting IL‐1β as a candidate therapeutic target to reverse immunosuppression and potentiate immune checkpoint blockade.…”
Get full text
Article -
246
Spontaneous Complete Regression of Colon Cancer Liver Metastases in a Lung Transplant Patient: A Case Report
Published 2023-01-01“…The cause of malignancies in patients with solid organ transplants is multifactorial, but the use of intensive immunosuppression is regarded as an important factor. We describe the spontaneous, complete regression of colon cancer liver metastases, without initiation of antitumor therapy, in a solid organ transplant patient after modulation of immunosuppressants. …”
Get full text
Article -
247
Pneumonia by Listeria monocytogenes: A Common Infection by an Uncommon Pathogen
Published 2015-01-01“…Infections by Listeria monocytogenes typically occur in infants, the elderly, pregnant women, and immunosuppressed subjects. Pulmonary infections in adults are extremely uncommon and only few reports can be found in the literature. …”
Get full text
Article -
248
Cerebellar Involvement in an Immunocompetent Patient Presenting with Progressive Multifocal Leukoencephalopathy
Published 2017-01-01“…We were not able to identify any occult immunosuppression or malignancy in our patient.…”
Get full text
Article -
249
Presumed ocular tuberculosis in a developed country: a descriptive retrospective analysis of patients from a tertiary health care centre in the United Kingdom
Published 2025-01-01“…Uveitis pattern and presence or absence of disc edema could predict the need for immunosuppression.…”
Get full text
Article -
250
Pneumonia Severity Index in the Immunocompromised
Published 2006-01-01“…BACKGROUND: The pneumonia severity index (PSI) accounts for many comorbidities, but not immunosuppression.…”
Get full text
Article -
251
A Case of Acute Hepatitis E Infection in a Patient with Non-Hodgkin Lymphoma Treated Successfully with Ribavirin
Published 2017-01-01“…We present the case of a man who, following immunosuppressive treatment for non-Hodgkin lymphoma, became infected with viral hepatitis E. …”
Get full text
Article -
252
Neoantigen mRNA vaccines and A2A receptor antagonism: A strategy to enhance T cell immunity
Published 2025-12-01“…By targeting A2AR, this approach reduces TME-induced immunosuppression, enhances DC activation, and improves neo-antigen presentation. …”
Get full text
Article -
253
CNS Vasculitis Associated with Waldenström Macroglobulinemia
Published 2016-01-01“…To our knowledge, CNS vasculitis in a WM patient, in the absence of cryoglobulins, has not been reported. Immunosuppression is the preferred treatment.…”
Get full text
Article -
254
Collecting Duct Carcinoma of the Native Kidney in a Renal Transplant Recipient
Published 2017-01-01“…To our knowledge, CDC in the setting of renal transplant and long-term immunosuppression has not been previously described.…”
Get full text
Article -
255
Early Gastric Post-Transplant Lymphoproliferative Disorder and H pylori Detection after Kidney Transplantation: A Case Report and Review of the Literature
Published 2000-01-01“…In the era of cyclosporine immunosuppression, the incidence of PTLD affecting the gastrointestinal tract may be increasing in comparison with the incidence seen with the use of older immunosuppression regimens. …”
Get full text
Article -
256
Spontaneous Pneumomediastinum due to Anti-Melanoma Differentiation-Associated Protein 5 Requiring a Bilateral Lung Transplant
Published 2021-01-01“…In medical literature, aggressive immunosuppressive therapy has been the mainstay of anti-MDA5-associated SPM management. …”
Get full text
Article -
257
A Decade of Experience Using mTor Inhibitors in Liver Transplantation
Published 2011-01-01“…Patients that received SRL as primary immunosuppression had 50% less rejection compared to controls.…”
Get full text
Article -
258
Prospective Study of BK Virus Infection in Patients with Inflammatory Bowel Disease
Published 2014-01-01“…A clear impact of the immunosuppressive regimen on BKV infection could not be demonstrated.…”
Get full text
Article -
259
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors
Published 2013-01-01“…The mammalian target of rapamycin inhibitors (mTOR-I), sirolimus and everolimus, are immunosuppressive drugs largely used in renal transplantation. …”
Get full text
Article -
260
miR-129-5p Regulates the Immunomodulatory Functions of Adipose-Derived Stem Cells via Targeting Stat1 Signaling
Published 2019-01-01“…One advantage of ASC-based therapy lies in their immunosuppressive potential. However, how to get ASCs to provide consistent immunosuppression remains unclear. …”
Get full text
Article